BackSarda Proteins Overview
Sarda Proteins Ltd.

Sarda Proteins Return on Equity

Sarda Proteins (SRDAPRT.BO) has a ROE of 92.54%, above the sector sector average of 11.3%.

Get informed when a big investor buys or sells

+ Follow

ROE

92.54%

Return on Equity

92.54%

Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.

ROE (Comparison Companies)

Loading

ROE History

Loading

ROE Comparison

Loading

Sarda Proteins (SRDAPRT.BO) FAQ

Sarda Proteins's return on equity stands at 92.54%. That is above the sector sector average of 11.3%. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.

Sarda Proteins sits higher the its sector benchmark (11.3%) with a ROE of 92.54%. That is roughly 719.2% above the sector mean. Peer context matters because what looks expensive or cheap in absolute terms can be normal for the sector.

A ROE of 92.54% for Sarda Proteins means each unit of related capital or sales is generating that return rate. Higher is usually better for profitability metrics, but extremely high figures can reflect one-time items or thin equity bases. Review several years of data on this page before extrapolating.

The history chart shows how Sarda Proteins's ROE evolved across reporting periods, while the comparison chart places SRDAPRT.BO next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.